The paradox of low BNP levels in obesity
- 27 April 2011
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 17 (1) , 81-96
Abstract
The aim of this review is to analyze in detail some possible pathophysiological mechanisms linking obesity and cardiac endocrine function, in order to try to explain the negative association previously observed between BMI and BNP values in both healthy subjects and patients with cardiovascular diseases. In particular, we discuss the hypothesis that the response of the cardiac endocrine system is the integrated resultant of several and contrasting physiological and pathological interactions, including the effects of peptide and steroid hormones, cytokines, cardiovascular hemodynamics, clinical conditions, and pharmacological treatment. Several studies suggested that gonadal function regulates both body fat distribution and cardiac endocrine function. Visceral fat expansion can increase the clearance of active natriuretic peptides by means of an increased expression of clearance receptors on adipocytes, and in this way, it may contribute to decrease the activity of the cardiac endocrine system. Moreover, obesity is associated with ectopic lipid deposition even in the heart, which may directly exert a lipotoxic effect on the myocardium by secreting in loco several cytokines and adipokines. Obese subjects are frequently treated for hypertension and coronary artery disease. Pharmacological treatment reduces plasma level of cardiac natriuretic peptides, and this effect may explain almost in part the lower BNP levels of some asymptomatic subjects with increased BMI values. At present time, it is not possible to give a unique and definitive answer to the crucial question concerning the inverse relationship between the amount of visceral fat distribution and BNP levels. Our explanation for these unsatisfactory results is that the cardiac endocrine response is always the integrated resultant of several pathophysiological interactions. However, only few variables can be studied together; as a result, it is not possible to perform a complete evaluation of pathophysiological mechanisms under study. We are still not able to well integrate these multiple information together; therefore, we should learn to do it.Keywords
This publication has 170 references indexed in Scilit:
- Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytesClinical Science, 2010
- Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytesLife Sciences, 2010
- Lipotoxicity in the heartBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studiesJournal of Clinical Epidemiology, 2010
- Is a Pre-Operative Brain Natriuretic Peptide or N-Terminal Pro–B-Type Natriuretic Peptide Measurement an Independent Predictor of Adverse Cardiovascular Outcomes Within 30 Days of Noncardiac Surgery?JACC, 2009
- Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptideVascular Pharmacology, 2009
- A New Role for the Natriuretic PeptidesJACC, 2009
- The implications of human metabolic network topology for disease comorbidityProceedings of the National Academy of Sciences, 2008
- The human disease networkProceedings of the National Academy of Sciences, 2007
- N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older AdultsJAMA, 2005